WHO Recommends Twice-Yearly Lenacapavir Injection to Prevent HIV
The World Health Organization has officially recommended the use of lenacapavir, a twice-yearly injectable developed by Gilead Sciences, as a preventive measure against HIV infection.…
The World Health Organization has officially recommended the use of lenacapavir, a twice-yearly injectable developed by Gilead Sciences, as a preventive measure against HIV infection.…
UNAIDS Executive Director and UN Undersecretary-General Winnie Byanyima has called for a major and transparent reduction in the price of lenacapavir, a newly approved long-acting…